ImmunityBio vs ImmunoScape
ImmunityBio vs ImmunoScape, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ImmunityBio is on 44/100 and ImmunoScape on 58/100.
Where each one leads
ImmunityBio
- domain rating: 53/100 against 28/100
- funding raised: $75.0M against $49.7M
- LinkedIn following: 32,397 against 4,364
ImmunoScape
- our overall score: 58/100 against 44/100
- agent readiness: 39/100 against 26/100
At a glance
| Measure | ImmunityBio | ImmunoScape |
|---|---|---|
| What it is | A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases. | Developing novel immunotherapies and diagnostics for cancer. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Immunotherapy | Biotechnology, Cancer, Immunotherapy, Diagnostics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2014 | 2017 |
| Headquarters | Culver City, USA | Singapore, Singapore |
| Status | Active | Active |
Size, funding and growth
| Measure | ImmunityBio | ImmunoScape |
|---|---|---|
| Employees | 620 | Not published |
| Total funding | $75.0M | $49.7M |
| Latest round | Funding Round | Series B2 |
| Valuation | $1.1B | $1.1B |
| LinkedIn followers | 32,397 | 4,364 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ImmunityBio | ImmunoScape |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 58/100 |
| Traction | 59/100 | 38/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 33/100 | 23/100 |
| Quality | 45/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (26/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 53/100 | 28/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ImmunityBio | ImmunoScape |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Google Tag Manager, Facebook Pixel | Google Tag Manager |
| Support stack | HubSpot | Not detected |
What users say
| Measure | ImmunityBio | ImmunoScape |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 6 positive, 0 negative across 6 threads |
“Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments.”r/Quantisnow
ImmunityBio vs ImmunoScape: common questions
Which is better, ImmunityBio or ImmunoScape?
On our 0-100 score ImmunoScape rates higher (58/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do ImmunityBio and ImmunoScape compare on the numbers?
ImmunityBio leads on domain rating (53/100 against 28/100), funding raised ($75.0M against $49.7M), LinkedIn following (32,397 against 4,364). ImmunoScape leads on our overall score (58/100 against 44/100), agent readiness (39/100 against 26/100).
What do real users say about ImmunityBio and ImmunoScape?
ImmunoScape: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/Quantisnow.
Read the full ImmunityBio review and pricing or the ImmunoScape review and pricing. You can also browse other ImmunityBio alternatives we track.